{"id":"https://openalex.org/W1995276446","doi":"https://doi.org/10.1185/03007990903223739","title":"Pharmacokinetics and pharmacodynamics of insulin lispro protamine suspension compared with insulin glargine and insulin detemir in type 2 diabetes","display_name":"Pharmacokinetics and pharmacodynamics of insulin lispro protamine suspension compared with insulin glargine and insulin detemir in type 2 diabetes","alternate_titles":[],"publication_year":2009,"publication_date":"2009-09-17","ids":{"openalex":"https://openalex.org/W1995276446","doi":"https://doi.org/10.1185/03007990903223739","mag":"1995276446","pmid":"https://pubmed.ncbi.nlm.nih.gov/19761358"},"language":"en","primary_location":{"id":"doi:10.1185/03007990903223739","doi":"https://doi.org/10.1185/03007990903223739","is_oa":false,"landing_page_url":"https://doi.org/10.1185/03007990903223739","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1995276446"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044166679","display_name":"Marcus Hompesch","orcid":"https://orcid.org/0000-0001-5867-2131","observed_orcids":["https://orcid.org/0000-0001-5867-2131"]},"institutions":[{"id":"https://openalex.org/I4210134048","display_name":"Profil Institute for Clinical Research","ror":"https://ror.org/03f2dkv17","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210134048"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marcus Hompesch","raw_affiliation_strings":["Profil Institute for Clinical Research, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Profil Institute for Clinical Research, Inc., San Diego, CA, USA","institution_ids":["https://openalex.org/I4210134048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022845875","display_name":"Scott M. Ocheltree","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott M. Ocheltree","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034773354","display_name":"Eshetu T. Wondmagegnehu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eshetu T. Wondmagegnehu","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084625858","display_name":"Linda Morrow","orcid":"https://orcid.org/0000-0003-3252-4477","observed_orcids":["https://orcid.org/0000-0003-3252-4477"]},"institutions":[{"id":"https://openalex.org/I4210134048","display_name":"Profil Institute for Clinical Research","ror":"https://ror.org/03f2dkv17","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210134048"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linda A. Morrow","raw_affiliation_strings":["Profil Institute for Clinical Research, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Profil Institute for Clinical Research, Inc., San Diego, CA, USA","institution_ids":["https://openalex.org/I4210134048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031141146","display_name":"Alexa P. Kollmeier","orcid":"https://orcid.org/0000-0002-2059-7866","observed_orcids":["https://orcid.org/0000-0002-2059-7866"]},"institutions":[{"id":"https://openalex.org/I4210134048","display_name":"Profil Institute for Clinical Research","ror":"https://ror.org/03f2dkv17","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210134048"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexa P. Kollmeier","raw_affiliation_strings":["Profil Institute for Clinical Research, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Profil Institute for Clinical Research, Inc., San Diego, CA, USA","institution_ids":["https://openalex.org/I4210134048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009432167","display_name":"Barbara N. Campaigne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barbara N. Campaigne","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110236818","display_name":"Scott J. Jacober","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Scott J. Jacober","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5110236818"],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":null,"apc_paid":null,"fwci":3.4272,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":{"value":0.9248363,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"25","issue":"11","first_page":"2679","last_page":"2687"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.5756999850273132,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.5756999850273132,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.40700000524520874,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/insulin-glargine","display_name":"insulin glargine","score":0.9810000061988831},{"id":"https://openalex.org/keywords/insulin-detemir","display_name":"insulin detemir","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.921999990940094},{"id":"https://openalex.org/keywords/glucose-lowering-activity","display_name":"glucose-lowering activity","score":0.7210000157356262},{"id":"https://openalex.org/keywords/basal-insulin","display_name":"basal insulin","score":0.5640000104904175},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.43700000643730164},{"id":"https://openalex.org/keywords/hyperinsulinemic-euglycemic-clamp","display_name":"hyperinsulinemic-euglycemic clamp","score":0.8140000104904175},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7360000014305115},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9909999966621399},{"id":"https://openalex.org/keywords/basal-insulin-analogues","display_name":"basal insulin analogues","score":0.4129999876022339},{"id":"https://openalex.org/keywords/carryover-effects","display_name":"residual effects","score":0.6320000290870667}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8191759586334229},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.7116939425468445},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6264219284057617},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5844254493713379},{"id":"https://openalex.org/C2776486108","wikidata":"https://www.wikidata.org/wiki/Q3492616","display_name":"Insulin lispro","level":4,"score":0.5513772368431091},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.548218846321106},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5265857577323914},{"id":"https://openalex.org/C2780677441","wikidata":"https://www.wikidata.org/wiki/Q410965","display_name":"Insulin detemir","level":5,"score":0.5161360502243042},{"id":"https://openalex.org/C2779920387","wikidata":"https://www.wikidata.org/wiki/Q417317","display_name":"Insulin glargine","level":4,"score":0.5071499347686768},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5025525093078613},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.4970710575580597},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.44066035747528076},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.08722314238548279},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069036","descriptor_name":"Insulin Glargine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069057","descriptor_name":"Insulin Detemir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011479","descriptor_name":"Protamines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011479","descriptor_name":"Protamines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011479","descriptor_name":"Protamines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013535","descriptor_name":"Suspensions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049528","descriptor_name":"Insulin, Long-Acting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061268","descriptor_name":"Insulin Lispro","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1185/03007990903223739","doi":"https://doi.org/10.1185/03007990903223739","is_oa":false,"landing_page_url":"https://doi.org/10.1185/03007990903223739","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},{"id":"pmid:19761358","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19761358","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medical research and opinion","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9789000153541565,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1966494009","https://openalex.org/W1968865647","https://openalex.org/W1971491729","https://openalex.org/W1987720472","https://openalex.org/W1995520690","https://openalex.org/W2065518778","https://openalex.org/W2071173797","https://openalex.org/W2096539888","https://openalex.org/W2126781806","https://openalex.org/W2127521907","https://openalex.org/W2133807304","https://openalex.org/W2134293572","https://openalex.org/W2149194615","https://openalex.org/W2158144637","https://openalex.org/W2170031373"],"related_works":["https://openalex.org/W2112879449","https://openalex.org/W1996687073","https://openalex.org/W2497403152","https://openalex.org/W1984353760","https://openalex.org/W2133807304","https://openalex.org/W2076232779","https://openalex.org/W2130931445","https://openalex.org/W1965568752","https://openalex.org/W3031926561","https://openalex.org/W2030525485"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1,130,193,274],"primary":[2,322],"aim":[3],"was":[4,113,141,145,281],"to":[5,29,71,118,147,299],"evaluate":[6,46],"duration":[7,33,131],"of":[8,10,16,34,36,54,83,90,111,132,162,166,245,269,277,317],"action":[9,35,112,134,318],"a":[11,61,72,77,170,199,230,303],"single":[12,78,231],"0.8":[13,80,94,139,171,232],"U/kg":[14,81,140,172,233],"dose":[15,52,82,226,234],"insulin":[17,133,291],"lispro":[18],"protamine":[19],"suspension":[20],"(ILPS)":[21],"in":[22,219,235,271],"type":[23],"2":[24],"diabetes":[25],"(T2DM)":[26],"patients;":[27],"secondarily":[28],"compare":[30],"onset":[31,316],"and":[32,40,45,49,85,87,96,99,144,152,178,182,206,221,240,248,256,258,285,319],"ILPS,":[37,238],"glargine":[38],"(G),":[39,177],"detemir":[41],"(D)":[42],"(0.8":[43],"U/kg)":[44,98],"pharmacokinetic":[47],"(PK)":[48],"pharmacodynamic":[50],"(PD)":[51],"responses":[53],"ILPS.":[55],"RESEARCH":[56],"DESIGN":[57],"AND":[58],"METHODS:":[59],"In":[60],"single-center,":[62],"double-blind,":[63],"five-arm":[64],"crossover":[65],"study,":[66],"34":[67],"patients":[68,293],"were":[69,100,184],"randomized":[70],"treatment":[73],"sequence":[74],"which":[75],"included":[76],"subcutaneous":[79],"G":[84,148,190,212],"D":[86,153,241],"three":[88],"doses":[89],"ILPS":[91,137,188,195,215,249,270],"(0.4":[92],"U/kg,":[93,95],"1.2":[97],"studied":[101],"using":[102],"24-hour":[103,278],"euglycemic":[104],"glucose":[105,122,127],"clamps.":[106,128],"PRIMARY":[107],"OUTCOME":[108],"MEASURE:":[109],"Duration":[110],"determined":[114],"as":[115],"the":[116,119,160,225,286,321],"time":[117],"last":[120],"measurable":[121],"infusion":[123],"rate":[124],"(tR(last))":[125,135],"during":[126],"RESULTS:":[129],"for":[136,187,289],"at":[138],">23":[142],"hours":[143,165],"similar":[146,243],"(p":[149,154],"=":[150,155],"0.114)":[151],"0.570).":[156],"Post-hoc":[157],"analysis":[158],"demonstrated":[159,198,216,242,250],"probability":[161],"achieving":[163],"24":[164],"glucose-lowering":[167,246,253],"activity":[168,247,254],"after":[169],"dose:":[173],"48%":[174],"(ILPS),":[175],"43%":[176],"26%":[179],"(D).":[180],"G(tot)":[181],"R(max)":[183],"significantly":[185,200,251],"greater":[186,252],"versus":[189,210],"or":[191,213],"D.":[192,214],"median":[194],"time-dependent":[196],"values":[197],"earlier":[201,259],"maximum":[202,260],"PD":[203,222,261],"response":[204],"(tR(max)":[205],"early":[207],"50%":[208],"tR(max))":[209],"either":[211],"dose-dependent":[217],"increases":[218],"PK":[220],"measures":[223],"across":[224],"range.":[227],"CONCLUSIONS:":[228],"Following":[229],"T2DM":[236],"patients,":[237],"G,":[239],"durations":[244],"(R(max)":[255],"G(tot))":[257],"response.":[262],"These":[263],"results":[264],"potentially":[265,313],"support":[266],"once-daily":[267],"dosing":[268],"T2DM.":[272],"LIMITATIONS:":[273],"observed":[275],"number":[276],"censored":[279],"observations":[280],"higher":[282],"than":[283],"expected":[284],"wash-out":[287],"period":[288],"basal":[290],"treated":[292],"may":[294],"have":[295],"been":[296],"too":[297],"short":[298],"definitively":[300],"rule":[301],"out":[302],"carry-over":[304],"effect;":[305],"however,":[306],"such":[307],"an":[308],"effect,":[309],"if":[310],"present,":[311],"would":[312],"only":[314],"affect":[315],"not":[320],"outcome":[323],"measure.":[324]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1995276446","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":7}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}
